Detect Lysosomal Storage Diseases

Sponsored, no-charge genetic testing for lysosomal storage diseases

 

Patients: Start an order

The Lysosomal Storage Diseases (LSDs) — also known as lysosomal disorders and lysosomal disease — genetic testing program provides access to sponsored, no-charge genetic testing and counseling for people suspected of having a lysosomal storage disease.

About lysosomal storage diseases

  • LSDs are inherited metabolic diseases characterized by the accumulation of toxic substrates in the lysosomes due to specific enzyme deficiencies

  • There are approximately 50 different diseases that are categorized as lysosomal storage diseases

  • LSDs are progressive, multisystemic conditions associated with high morbidity and mortality; many are not apparent at birth

  • Early identification of affected individuals provides the opportunity to investigate potential treatment options, allowing for the possibility of improved clinical outcomes

Eligibility

Learn more

Panel

Learn more

Ordering instructions

Learn more

Program eligibility

To qualify for no-charge testing through the Invitae Detect LSDs program, individuals in the US and Canada must be suspected of having a lysosomal storage disease based on at least one of the following:

  • Clinical features
  • Suspicion of, or known diagnosis of, a specific lysosomal storage disease
  • Family history related to LSDs
  • Lab result suggestive of LSDs
  • Presumptive positive newborn screening

Genetic testing with Invitae

The Invitae Detect LSDs program offers testing with multiple panels as well as with single genes. If the test comes back negative, clinicians have the option of re-requisition to another panel within the original clinical area.

Metabolic clinical area

Comprehensive LSDs panel*

analyzes up to 53 genes associated with lysosomal storage diseases

View panel

Comprehensive MPS Panel

analyzes genes associated with mucopolysaccharidoses

View panel

Cardiology / neurology clinical area

Cardiomyopathy comprehensive panel

provides a comprehensive analysis of the genes associated with inherited cardiomyopathy conditions

View panel

Comprehensive neuromuscular disorders panel

analyzes up to 123 genes that are associated with inherited neuromuscular disorders, including muscular dystrophies, myopathies, and congenital myasthenic syndromes

View panel

  • You can also order single genes from the metabolic clinical area. To view those genes, view the paper order form.

  • All single-gene orders that come back negative have the option to re-requisition to the metabolic clinical area.

  • Once Invitae receives a patient’s blood or saliva specimen, their results will be available approximately within 10 to 21 calendar days, on average.

*This panel does not currently test for Gaucher diesease.

Sponsored genetic counseling

Individuals tested through the Detect LSDs program are eligible for post-test genetic counseling to help them understand their test results. This service is provided through GeneMatters, a third-party genetic counseling service, and is made available by Invitae at no charge as part of the program. To schedule a genetic counseling appointment, please contact GeneMatters at 1-866-741-5331 or schedule online at www.gene-matters.com (use partner code: LYSO).

More information for clinicians

Download flyer

Already been tested through Detect LSDs?

Download flyer

Ordering made easy

Clinicians can place an order by follwing the steps below.

Place your order Collect a specimen Results

To place a paper-based order, download the paper order form.

To place an order online:

  1. Sign up for an account and start a new order
  2. Under Test Selection, click on the Partnership Programs tab and enter LYSO in the Invitae Partner Code field
  3. Use the search bar to find and select one of the testing options above
  4. Fill in the required patient information
  5. Under Billing Information, select Institutional Billing and leave all fields blank
  6. Complete the Order Authorization section and submit the order
  7. Fill out, print, and sign the eligibility criteria form, which includes a required physician consent, and include it with the specimen

To collect a specimen:

  1. Order a specimen collection kit
  2. Collect the specimen and ship it back to Invitae
  3. Include the signed eligibility criteria form with the specimen
  4. For additional information, please see specimen and shipping requirements

To receive results:

  1. Once Invitae receives the sample, you will receive the results in 10-21 calendar days, on average
  2. If you created an online account, you can view the status of your order by logging into your account
  3. You will receive a notification email once the test results are ready

 

Are you a patient?

If you're a patient and believe you are eligible for this sponsored testing program, you can contact Genome Medical, our third-party telemedicine genetics provider, or work with your healthcare provider.

Support every step of the way

Client services

Invitae is available to answer your questions or help you through the testing process.

Contact

Family Testing

If the test comes back positive, all of the proband’s blood relatives are eligible for the program using program code LYSO.

The Detect LSDs program includes testing for the following disorders:

Mucopolysaccharidoses

MPS I, MPS II, MPS IIIA, MPS IIIB, MPS IIIC, MPS IIID, MPS IVa, MPS IVb, MPS VI, MPS VII, MPS IX

Sphingolipidoses

Fabry disease, Farber disease, GM1 gangliosidosis, GM2-gangliosidosis AB variant, Galactosialidosis, Krabbe disease, Metachromatic leukodystrophy, Multiple sulfatase deficiency, Niemann-Pick A, B, Prosaposin deficiency, Tay-Sachs disease, Sandhoff disease, SapA deficiency (Krabbe variant), SapB deficiency (MLD variant), SapC deficiency (Gaucher variant)

Mucolipidoses

Mucolipidosis type I, Mucolipidosis type II alpha/beta, Mucolipidosis III alpha/beta, Mucolipidosis III gamma, Mucolipidosis type I

Neuronal ceroid lipofuscinoses

CLN1, CLN2, CLN3, CLN5, CLN6, CLN7, CLN8, CLN9, CLN10, CLN14 (Opt in: CLN4, CLN11, CLN12, CLN13)

Oligosaccharidoses

Alpha-mannosidosis, Aspartylglucosaminuria, beta-mannosidosis, Fucosidosis, Pycnodysostosis, Schindler disease, Sialidosis I

Lysosomal transport defects

Cystinosis, Infantile sialic acid storage disease, Salla disease

Lipid storage defects

Niemann-Pick C, Lysosomal acid lipase deficiency

Glycogen storage disease II

Pompe disease

Lysosomal-associated membrane proteins

Danon disease

Detect LSDs is offered in partnership with the following sponsors:

neurogene

Explore relevant advocacy organizations

About Invitae

Invitae is a genetic information company whose mission is to bring genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae provides clinical-grade, medically actionable genetic information to answer essential health questions across all stages of life.

Disclaimer

While third parties and commercial organizations may provide financial support for this program, tests and services are performed by Invitae. Healthcare professionals must confirm that patients meet certain criteria to use the program. Third parties and commercial organizations may receive de-identified patient data from this program, but at no time would they receive patient identifiable information. Third parties and commercial organizations may receive contact information for healthcare professionals who use this program. Genetic testing and counseling are available in the US and Canada. Healthcare professionals and patients who participate in this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use or support any other products or services from Invitae or from third parties or commercial organizations.